Navigation Links
Synteract Director of IT Services Toby Odenheim Speaking at March 2012 Outsourcing in Clinical Trials East Coast Conference
Date:3/19/2012

SAN DIEGO and PHILADELPHIA, March 19, 2012 /PRNewswire/ -- Toby Odenheim, director of IT services at Synteract, Inc., a full-service contract research organization (CRO), is slated to present on Selecting the Optimum EDC Platform to Support your Clinical Program at the Outsourcing in Clinical Trials, East Coast conference, to be held in Philadelphia, March 27-28, 2012. Odenheim will speak at 11 a.m. EDT, Wed., March 28, discussing a variety of drivers to consider when selecting the right EDC (electronic data capture) platform for clinical project needs.

(Logo: http://photos.prnewswire.com/prnh/20111108/MM02925LOGO)

The conference is geared towards solution-seeking professionals who want focused research-generated content and innovative strategies to manage the increased complexities in today's drug development environment. Odenheim will discuss working with clients to identify the key drivers for consideration when evaluating electronic data capture platforms to match program needs, such as:

  • Developing a checklist and risk-benefit evaluation to assist in decision-making
  • Assessing different platforms during a clinical program to enhance productivity, cost efficiency and expedite decision points
  • Scrutinizing EDC systems for biotech and pharma development needs

Odenheim has been with Synteract for seven years. He has a master's in business administration and a bachelor's degree in biology, as well as a professional Oracle Database Administration certificate from the University of California San Diego.

According to Stewart Bieler, chief operating officer, Odenheim was chosen to present on behalf of Synteract due to his clear understanding of how critical the application of appropriate technologies is in driving efficiencies and productivity in drug development.

"This is a complex industry that is changing all the time, and clients want to be assured their project will be in the right hands, with a company that has experience helping clients choose the right tools and technology for their drug development needs. Toby has assessed and helped to deliver solutions to clients that best fit their unique program requirements, driving projects and results forward at the same time."

Synteract will exhibit in booth #35; Synteract CEO, Wendel Barr, will also be on hand at the event. Synteract will answer questions about the multiple software and technology platforms it supports within the framework of its full-service CRO capabilities and will discuss how its more than 17 years of experience across a wide range of therapeutic areas can fit specific project needs. To set up an appointment in advance, contact Michele Sacher, associate business development director, at 484.467.5937 or at msacher@synteract.com 

About Synteract (www.synteract.com)

Synteract is a full-service contract research organization with a successful 17-year track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development.  With its "Shared Work – Shared Vision" philosophy Synteract provides customized Phase I through IV services collaboratively and cost effectively to ensure on-time delivery of quality data so clients get to decision points faster. Headquartered in California, with offices in North Carolina and the Czech Republic, Synteract delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, cardiovascular, respiratory and ophthalmology. 

CONTACT:
Rachel Hutman
Clearpoint Agency, for Synteract
rachel@clearpointagency.com
760-230-2424

 


'/>"/>
SOURCE Synteract, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
2. InspireMD Appoints Dr. James Barry to Its Board of Directors
3. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
4. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
5. Berkeley Lab Director Paul Alivisatos wins Wolf Prize in Chemistry
6. Oxford BioTherapeutics Appoints C. Glenn Begley as a Senior Clinical Advisor and Non-executive Director
7. Robert Farrell Joins Bionovos Board of Directors
8. Sinovac Announces Resignation of Chup Hung Mok from Board of Directors
9. Fate Therapeutics Announces the Appointment of William H. Rastetter as Chairman of its Board of Directors and Interim CEO
10. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
11. BioStorage Technologies Appoints New Member to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, ... biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide ... email client designed to provide product vigilance departments with the flexibility and ease ...
(Date:1/19/2017)... ... January 18, 2017 , ... The American Medical Informatics Association ... Data Sharing Policy. Specifically, the nation’s leading informatics experts, said data sharing plans ... policy. AMIA recommended that NIH earmark funding for researchers to produce and execute ...
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/18/2017)... OR (PRWEB) , ... January 18, 2017 , ... ... that provide essential device-to-computer interconnect using USB or PCI Express, announced the ZEM5310 ... Cyclone V E FPGA into a compact business-card sized form factor suitable for ...
Breaking Biology Technology:
(Date:12/22/2016)...  As part of its longstanding mission to improve genetic ... recently released its latest children,s book, titled The ... the topics of inheritance and variation of traits that are ... elementary school classrooms in the US. The ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
(Date:12/16/2016)... Research and Markets has announced the addition ... to 2021" report to their offering. ... The biometric vehicle access system market, ... of 14.06% from 2016 to 2021. The market is estimated to ... 854.8 Million by 2021. The growth of the biometric vehicle access ...
Breaking Biology News(10 mins):